Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationStem CellsHematopoietic Stem Cell MobilizationMelphalanMultiple MyelomaHematopoietic Stem CellsCombined Modality TherapyLeukapheresisTransplantation ConditioningGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Transplantation, HomologousBlood Component RemovalCyclophosphamideTreatment OutcomeRemission InductionEtoposideThiotepaSalvage TherapyLymphoma, Non-HodgkinBone Marrow TransplantationHodgkin DiseaseDisease-Free SurvivalHematologic NeoplasmsBone Marrow PurgingMyeloablative AgonistsRecurrenceCytarabineVincristineCarmustineBusulfanGraft SurvivalGraft vs Host DiseaseAmyloidosisAdult Stem CellsSurvival RateAntineoplastic Agents, AlkylatingIfosfamideWhole-Body IrradiationDoxorubicinSurvival AnalysisDexamethasoneEmbryonic Stem CellsPluripotent Stem CellsRetrospective StudiesBlood CellsLymphoma, Mantle-CellHematopoiesisTime FactorsLymphomaLeukocytes, MononuclearAntibodies, Monoclonal, Murine-DerivedLymphoma, T-Cell, PeripheralMesenchymal Stem Cell TransplantationCell DifferentiationBoronic AcidsCells, CulturedStem Cell NichePodophyllotoxinPyrazinesBlood Cell CountFlow CytometryFollow-Up StudiesPrognosisLymphoma, FollicularNeural Stem CellsCord Blood Stem Cell TransplantationBone Marrow CellsInduced Pluripotent Stem CellsThalidomideBone MarrowMesenchymal Stromal CellsPrednisoneStem Cell FactorCell SeparationNeoplasm, ResidualPlatelet CountCarboplatinImmunophenotypingMitoxantroneMultipotent Stem CellsImmunomagnetic SeparationT-LymphocytesAutograftsTissue DonorsFeasibility StudiesAntineoplastic AgentsPlant StemsLeukemia, Myeloid, AcuteLeukocyte CountAntibodies, MonoclonalIdarubicinBlood Transfusion, AutologousNeoplasmsRecombinant ProteinsTransplantation Chimera